KYMR

Kymera Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$85.40

Market Cap

$6.97B

Beta

2.30

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-16.72%

EPS Growth (YoY)-24.24%

Revenue CAGR 3Y-5.75%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.36%

Debt / Equity0.05

Interest Coverage-1403.2x

No credit card required

Already have an account? Sign in to view the full analysis for KYMR.